Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers

Anya N A Milne, Ralph Carvalho, Folkert M. Morsink, Alex R. Musler, Wendy W J De Leng, Ari Ristimäki, G. Johan A Offerhaus

Research output: Contribution to journalArticle

Abstract

Many studies examine the molecular genetics of gastric cancer, but few look at young patients in particular and there is no comparison of molecular expression between early-onset gastric cancer (≤45 years old) and conventional gastric cancers. Expression of cycloxygenase-2 (COX-2) is elevated in gastric adenocarcinomas compared to non-neoplastic mucosa, and in light of studies showing reduced risk of gastric cancer in nonsteroidal anti-inflammatory drug users, we have chosen to investigate the expression of COX-2 and related molecules in 113 early-onset gastric cancers and compare it with 91 conventional gastric cancers, using tissue microarrays. These markers include molecules known to be important in conventional gastric carcinogenesis, such as E-Cadherin, p53, COX-2, Trefoil Factor-1 (TFF1), β-catenin, p16 and c-myc; as well as molecules not yet described as being important in gastric cancer, such as the transcription factor c-jun, the COX-2 mRNA stabilizer HuR, and C/EBP-β, a transcription factor for COX-2. All markers showed a statistically significant difference between early-onset gastric cancers and conventional gastric cancers, using a χ2 test. In particular, early-onset gastric cancers displayed a COX-2 Low, TFF1-expressing phenotype, whereas COX-2 overexpression and loss of TFF1 was found in conventional cancers, and this difference between early-onset gastric cancers and conventional cancers remained statistically significant when adjusted for location and histology (P

Original languageEnglish (US)
Pages (from-to)564-572
Number of pages9
JournalModern Pathology
Volume19
Issue number4
DOIs
StatePublished - Apr 2006
Externally publishedYes

Fingerprint

Stomach Neoplasms
Stomach
Transcription Factors
Catenins
Cadherins
Drug Users
Molecular Biology
Neoplasms
Histology
Carcinogenesis
Mucous Membrane
Adenocarcinoma
Anti-Inflammatory Agents
Phenotype
Messenger RNA

Keywords

  • COX-2
  • Early-onset gastric cancer
  • TFF1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Milne, A. N. A., Carvalho, R., Morsink, F. M., Musler, A. R., De Leng, W. W. J., Ristimäki, A., & Offerhaus, G. J. A. (2006). Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Modern Pathology, 19(4), 564-572. https://doi.org/10.1038/modpathol.3800563

Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. / Milne, Anya N A; Carvalho, Ralph; Morsink, Folkert M.; Musler, Alex R.; De Leng, Wendy W J; Ristimäki, Ari; Offerhaus, G. Johan A.

In: Modern Pathology, Vol. 19, No. 4, 04.2006, p. 564-572.

Research output: Contribution to journalArticle

Milne, ANA, Carvalho, R, Morsink, FM, Musler, AR, De Leng, WWJ, Ristimäki, A & Offerhaus, GJA 2006, 'Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers', Modern Pathology, vol. 19, no. 4, pp. 564-572. https://doi.org/10.1038/modpathol.3800563
Milne, Anya N A ; Carvalho, Ralph ; Morsink, Folkert M. ; Musler, Alex R. ; De Leng, Wendy W J ; Ristimäki, Ari ; Offerhaus, G. Johan A. / Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. In: Modern Pathology. 2006 ; Vol. 19, No. 4. pp. 564-572.
@article{60033b51b80c4f4d9a9ea5ce459c2fda,
title = "Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers",
abstract = "Many studies examine the molecular genetics of gastric cancer, but few look at young patients in particular and there is no comparison of molecular expression between early-onset gastric cancer (≤45 years old) and conventional gastric cancers. Expression of cycloxygenase-2 (COX-2) is elevated in gastric adenocarcinomas compared to non-neoplastic mucosa, and in light of studies showing reduced risk of gastric cancer in nonsteroidal anti-inflammatory drug users, we have chosen to investigate the expression of COX-2 and related molecules in 113 early-onset gastric cancers and compare it with 91 conventional gastric cancers, using tissue microarrays. These markers include molecules known to be important in conventional gastric carcinogenesis, such as E-Cadherin, p53, COX-2, Trefoil Factor-1 (TFF1), β-catenin, p16 and c-myc; as well as molecules not yet described as being important in gastric cancer, such as the transcription factor c-jun, the COX-2 mRNA stabilizer HuR, and C/EBP-β, a transcription factor for COX-2. All markers showed a statistically significant difference between early-onset gastric cancers and conventional gastric cancers, using a χ2 test. In particular, early-onset gastric cancers displayed a COX-2 Low, TFF1-expressing phenotype, whereas COX-2 overexpression and loss of TFF1 was found in conventional cancers, and this difference between early-onset gastric cancers and conventional cancers remained statistically significant when adjusted for location and histology (P",
keywords = "COX-2, Early-onset gastric cancer, TFF1",
author = "Milne, {Anya N A} and Ralph Carvalho and Morsink, {Folkert M.} and Musler, {Alex R.} and {De Leng}, {Wendy W J} and Ari Ristim{\"a}ki and Offerhaus, {G. Johan A}",
year = "2006",
month = "4",
doi = "10.1038/modpathol.3800563",
language = "English (US)",
volume = "19",
pages = "564--572",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers

AU - Milne, Anya N A

AU - Carvalho, Ralph

AU - Morsink, Folkert M.

AU - Musler, Alex R.

AU - De Leng, Wendy W J

AU - Ristimäki, Ari

AU - Offerhaus, G. Johan A

PY - 2006/4

Y1 - 2006/4

N2 - Many studies examine the molecular genetics of gastric cancer, but few look at young patients in particular and there is no comparison of molecular expression between early-onset gastric cancer (≤45 years old) and conventional gastric cancers. Expression of cycloxygenase-2 (COX-2) is elevated in gastric adenocarcinomas compared to non-neoplastic mucosa, and in light of studies showing reduced risk of gastric cancer in nonsteroidal anti-inflammatory drug users, we have chosen to investigate the expression of COX-2 and related molecules in 113 early-onset gastric cancers and compare it with 91 conventional gastric cancers, using tissue microarrays. These markers include molecules known to be important in conventional gastric carcinogenesis, such as E-Cadherin, p53, COX-2, Trefoil Factor-1 (TFF1), β-catenin, p16 and c-myc; as well as molecules not yet described as being important in gastric cancer, such as the transcription factor c-jun, the COX-2 mRNA stabilizer HuR, and C/EBP-β, a transcription factor for COX-2. All markers showed a statistically significant difference between early-onset gastric cancers and conventional gastric cancers, using a χ2 test. In particular, early-onset gastric cancers displayed a COX-2 Low, TFF1-expressing phenotype, whereas COX-2 overexpression and loss of TFF1 was found in conventional cancers, and this difference between early-onset gastric cancers and conventional cancers remained statistically significant when adjusted for location and histology (P

AB - Many studies examine the molecular genetics of gastric cancer, but few look at young patients in particular and there is no comparison of molecular expression between early-onset gastric cancer (≤45 years old) and conventional gastric cancers. Expression of cycloxygenase-2 (COX-2) is elevated in gastric adenocarcinomas compared to non-neoplastic mucosa, and in light of studies showing reduced risk of gastric cancer in nonsteroidal anti-inflammatory drug users, we have chosen to investigate the expression of COX-2 and related molecules in 113 early-onset gastric cancers and compare it with 91 conventional gastric cancers, using tissue microarrays. These markers include molecules known to be important in conventional gastric carcinogenesis, such as E-Cadherin, p53, COX-2, Trefoil Factor-1 (TFF1), β-catenin, p16 and c-myc; as well as molecules not yet described as being important in gastric cancer, such as the transcription factor c-jun, the COX-2 mRNA stabilizer HuR, and C/EBP-β, a transcription factor for COX-2. All markers showed a statistically significant difference between early-onset gastric cancers and conventional gastric cancers, using a χ2 test. In particular, early-onset gastric cancers displayed a COX-2 Low, TFF1-expressing phenotype, whereas COX-2 overexpression and loss of TFF1 was found in conventional cancers, and this difference between early-onset gastric cancers and conventional cancers remained statistically significant when adjusted for location and histology (P

KW - COX-2

KW - Early-onset gastric cancer

KW - TFF1

UR - http://www.scopus.com/inward/record.url?scp=33645314360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645314360&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800563

DO - 10.1038/modpathol.3800563

M3 - Article

C2 - 16474375

AN - SCOPUS:33645314360

VL - 19

SP - 564

EP - 572

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 4

ER -